codiakbio.comHealthcareFounded: 2015Funding to Date: $168.37MM
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need.
View Enterprise Value for Codiak BioSciences.
